Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A de Lemos

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Electrocardiology|March 27, 2001
ST-Segment resolution as a marker of epicardial and myocardial reperfusion after thrombolysis: insights from the TIMI 14 and in TIME-II trialsJ A de Lemos
Journal of the American College of Cardiology|November 3, 2001
ST segment resolution as a tool for assessing the efficacy of reperfusion therapyJ A de Lemos, E Braunwald
Journal of the American Society of Nephrology : JASN|October 1, 1996
Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysisJ A de Lemos, L D Hillis
Heart (British Cardiac Society)|January 20, 2004
New tools for assessing microvascular obstruction in patients with ST elevation myocardial infarctionJ A de Lemos, J J Warner
Current Problems in Cardiology|October 5, 2001
Infective endocarditisL Mauri, J A de Lemos, P T O'Gara
Journal of the American College of Cardiology|August 10, 2000
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular riskJ A de Lemos, C H Hennekens, P M Ridker
American Heart Journal|August 2, 2001
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapyM A Blazing, J A De Lemos, C K Dyke, et al.
Clinical Chemistry|April 12, 2000
Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B SubstudyD A Morrow, N Rifai, M J Tanasijevic, et al.
Circulation|October 20, 1999
Images in cardiovascular medicine. Ebstein's anomaly associated with an anomalous coronary artery, 2 myocardial bridges, and a mahaim fiberJ A de Lemos, E Delacretaz, R N Piana, et al.
Kidney International|December 14, 2007
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohortU Baber, J A de Lemos, A Khera, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Electrocardiology|March 27, 2001
ST-Segment resolution as a marker of epicardial and myocardial reperfusion after thrombolysis: insights from the TIMI 14 and in TIME-II trialsJ A de Lemos
Journal of the American College of Cardiology|November 3, 2001
ST segment resolution as a tool for assessing the efficacy of reperfusion therapyJ A de Lemos, E Braunwald
Journal of the American Society of Nephrology : JASN|October 1, 1996
Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysisJ A de Lemos, L D Hillis
Heart (British Cardiac Society)|January 20, 2004
New tools for assessing microvascular obstruction in patients with ST elevation myocardial infarctionJ A de Lemos, J J Warner
Current Problems in Cardiology|October 5, 2001
Infective endocarditisL Mauri, J A de Lemos, P T O'Gara
Journal of the American College of Cardiology|August 10, 2000
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular riskJ A de Lemos, C H Hennekens, P M Ridker
American Heart Journal|August 2, 2001
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapyM A Blazing, J A De Lemos, C K Dyke, et al.
Clinical Chemistry|April 12, 2000
Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B SubstudyD A Morrow, N Rifai, M J Tanasijevic, et al.
Circulation|October 20, 1999
Images in cardiovascular medicine. Ebstein's anomaly associated with an anomalous coronary artery, 2 myocardial bridges, and a mahaim fiberJ A de Lemos, E Delacretaz, R N Piana, et al.
Kidney International|December 14, 2007
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohortU Baber, J A de Lemos, A Khera, et al.
Pageof 3